Xilio Therapeutics
31 hedge funds and large institutions have $33.5M invested in Xilio Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$18.1K | |
| 2 | +$850 | |
| 3 | +$211 | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$211 |
| 5 |
JPMorgan Chase & Co
New York
|
+$44 |
Top Sellers
| 1 | -$225K | |
| 2 | -$34.5K | |
| 3 | -$33.8K | |
| 4 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$26.2K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$7.68K |